National and Kapodistrian University of Athens
Διερεύνηση του ρόλου των πρωτεϊνών του συμπλόκου RISC στην ανάπτυξη ηπατικής παθολογίας, με έμφαση στο ηπατοκυτταρικό καρκίνωμα
Abstract
dc:descriptionPost-transcriptional and translational control comprise two of the most important generegulation mechanisms in eukaryotic organisms. In recent years, the discovery of new RNA species, with various properties, has significantly advanced our understanding of gene-expression regulation and cell signaling. To fulfill its role in the cell, RNA interacts with RNA-binding proteins (RBPs), forming complexes that facilitate key-cellular processes, such as cell differentiation, embryonic development and gene silencing. A major RNA/protein complex is RISC (RNA-induced silencing complex), which plays a crucial role in the RNA interference (RNAi) mechanism, a central posttranscriptional regulatory process. RISC consists of various proteins, such as the Argonautes (AGOs), DICER, TRBP2 and PACT. However, recent studies have highlighted new, fascinating, functions of these RNAi proteins in cellular processes, like cell division and DNA-damage repair. In the present study, using various experimental technologies methods, especially immunofluorescence and confocal laser scanning microscopy (high resolution), we investigated the role(s) of RISC proteins in local-homeostasis regulation, as well as the molecular mechanisms through which they are controlled, in both normal and pathological settings. Our results revealed novel, hitherto unknown, roles of TRBP2 and AGO2 proteins in cell-cycle regulation and cell division, two vital processes for proper-organism function. Specifically, TRBP2 expression was found to be tightly regulated during mitosis, a functional coupling that is not related to TRBP2 major role in RNAi mechanism, as it is evidenced by the different expression pattern of its co-factor, the PACT protein. This phenotype is also independent of oncogenic characteristics, metastatic potential, or molecular signature of cells, while in silico analysis indicates strong interaction potential between TRBP2 and other cell-cycle regulators, thus highlighting TRBP2 as a novel, and pivotal, molecule, for cell-growth control. Importantly, AGO2 was shown to play a key role in centrosome biosynthesis and mitoticspindle formation, both in “normal” and liver-cancer cells, with its co-localization with main centrosomal proteins further strengthening its importance in these mechanisms and processes. Our results strongly suggest for a non-canonical, microtubule network-dependent, RNAi mechanism, which tightly regulates local homeostasis, especially during cell division. Furthermore, examination of protein DROSHA, known for its role in miRNA biogenesis pathway, unveiled novel, possibly miRNA-independent, functions in Golgi apparatus. Notably, the strong correlation between DROSHA localization at Golgi apparatus and cancer phenotype, malignancy grade or/and metastatic status/dynamics indicates DROSHA involvement in invasionand metastasis of cancer cells. These results inform that DROSHA is likely engaged in the commencement and advancement of malignancies, via structural or/and functional alterations of Golgi apparatus. Taken together, the discovery of novel, hitherto unknown, non-canonical, functions of the above RNAi machinery-related proteins may constitute a springboard, for better understanding, and strongly illuminating, the molecular basis of several pathological conditions, including cancer, in humans, thereby, consequently leading to prompt development of targeted, and highly effective therapies, in the clinical practice, the years to come.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Theotoki, Eleni
- Θεοτόκη, Ελένη
Subjects
dc:subject × 17Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61112